
The medical director for Optegra has piloted corneal workflows and trifocal lenses presented at the meeting

The medical director for Optegra has piloted corneal workflows and trifocal lenses presented at the meeting

The director of Frankfurt’s Bürgerhospital eye hospital shared 7 years’ data on the iStent inject®

VR will have very useful applications in many fields. One of those fields is ophthalmology.

Resolution of macular leakage is an early biomarker of vascular stability.


An overview of Jesse Berry’s advice for starting and growing a social media account

Andrew Lee, MD, and Andrew Carey, MD, sit down on another episode of the NeuroOp Guru to discuss visual outcomes in solid versus cystic pituitary adenomas.

‘Modern Family’ actor and his mother, Jamey, are sharing their family’s story of GA and AMD to raise awareness of the disease.

Lisa M. Nijm, MD, JD, discusses the action-packed agenda of Real World Ophthalmology’s virtual event on September 30, 2023.

Leaders must confront issues perpetuating unequal access, unfair practices.

The theme calls on employers, insurers, and policy makers to consider how they can contribute to improved access to vision and eye health care.

Gabriel Diaz has received the Research to Prevent Blindness/Lions Clubs International Foundation Low Vision Research Award.

Research from Orbis International analyses the overall wellbeing of children with common childhood vision problems

RWO is hosting its 5th virtual, interactive conference titled “Top 10 Things I Wish I Knew Sooner” on Saturday September 30, 2023, from 8 am to 5:30 pm Central Time.

According to the company, GATHER-2 24-month results met the primary objective of reducing the rate of GA growth in patients treated with IZERVAY compared to sham.

Despite its status as an essential postoperative safety eye product and its utilization by every ocular surgeon with every ocular surgery, eye shield innovation has been neglected to date.

Earlier this year, the US Centers for Disease Control and Prevention issued an advisory, sounding the alarm for an outbreak of a drug resistant strain of the bacteria Pseudomonas aeruginosa that was connected to the use of artificial tears.

The company has released a video presentation that highlights combining genetic markers with high-resolution retinal imaging to assist in the detection and treatment of blindness and multiple systemic diseases.

Noncontact esthesiometry screens for all levels of neurotrophic keratitis.

The glaucoma specialist spoke about his ESCRS agenda–and his calendar for 2024

Stem cells may replace some lost retinal neurons

The week of September 18-24 will be dedicated to educating the public on IEDs such as uveitis, keratitis, conjunctivitis and more.

With a robust pipeline, new hope for Stargardt disease and retinitis pigmentosa may be on the horizon.

Clear communication, transparent priceing, options are key to positive experience

Few treatment options available for early stages of disease.

The diagnostics company is using AI to screen for diabetic retinopathy, glaucoma and age-related macular degeneration

Garg reported the 30-month data showing that patients receiving pegcetacoplan experienced an increasing treatment effect compared with sham (ie, a decrease in GA lesion area over time).

A panel of retina specialists review new and emerging treatments in neovascular AMD and DME, highlighting high-dose aflibercept and KSI-301. Which emerging treatments are you most interested in?

Research from Orbis International analyzes the overall wellbeing of children with common childhood vision problems.

According to a study, optical coherence tomography-based elastography holds promise for research and diagnosis of ocular diseases.